Difference between revisions of "Ovarian tumours"

Jump to navigation Jump to search
268 bytes added ,  23:40, 29 October 2012
(→‎IHC: more)
Line 487: Line 487:
* Increased risk of ovarian clear cell carcinoma ~ 3x.
* Increased risk of ovarian clear cell carcinoma ~ 3x.
* Seen in 50-70% of ovarian CCC.
* Seen in 50-70% of ovarian CCC.
===Gross===
*Usually unilateral (unlike [[serous carcinoma of the ovary|serous carcinoma]]).<ref name=pmid22885379/>


===Microscopic===
===Microscopic===
Line 505: Line 508:


DDx:
DDx:
*[[Serous carcinoma of the ovary]] - have larger papillae,<ref name=pmid22885379/> more group pleomorphism.
*[[Serous carcinoma of the ovary]] - have larger papillae +/- branching +/-multilayered epithelium, more mitotic activity,<ref name=pmid22885379/> more group pleomorphism.
*[[Serous borderline tumour of the ovary]].
*High-grade [[endometrioid carcinoma of the ovary]].
*High-grade [[endometrioid carcinoma of the ovary]].
*[[Metastasis|Metatstatic]] [[clear cell carcinoma]].
*[[Metastasis|Metatstatic]] [[clear cell carcinoma]], esp. [[clear cell renal cell carcinoma]].
*Borderline clear cell lesion of the ovary - very rare; an under sampled carcinoma considered more probable.<ref name=pmid22885379/>
*Borderline clear cell lesion of the ovary - very rare; an under sampled carcinoma considered more probable.<ref name=pmid22885379/>
*[[Arias-Stella reaction]] within [[endometriosis]].
*[[Arias-Stella reaction]] within [[endometriosis]].
48,702

edits

Navigation menu